n,n-di-n-propyldopamine has been researched along with apomorphine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, M; DeMarinis, RM; Franz, RG; Hieble, JP; Ross, ST; Sarau, HM; Wilson, JW | 1 |
| Arnerić, SP; Chow, SA; Fischer, LJ; Long, JP | 1 |
2 other study(ies) available for n,n-di-n-propyldopamine and apomorphine
| Article | Year |
|---|---|
Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro- 1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines.
Topics: Alkylation; Animals; Benzazepines; Caudate Nucleus; Cyclic AMP; Fenoldopam; Norepinephrine; Rabbits; Receptors, Dopamine | 1986 |
Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
Topics: Adrenal Medulla; Animals; Apomorphine; Blood Glucose; Bromocriptine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Ergolines; Indans; Insulin; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes | 1984 |